Septerna, Inc. (SEPN) income statement
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$39.45−0.57 (-1.42%)
Close on Nov 18, 2026Market cap $1.84BP/E –Yield –
Septerna, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -76.2%
- Net margin
- -61.3%
- Return on equity, FY2025
- -12.2%
Financial strength
- Current ratio
- 4.84
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 159.4%
Valuation
- P/E ratio
- –
- Price to sales
- 19.13
- Price to book
- 4.30
- Dividend yield
- –
See a number that looks wrong?